Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.

Literature DB >> 4449007

Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.

W G Kramer, R P Lewis, T C Cobb, W F Forester, J A Visconti, L A Wanke, H G Boxenbaum, R H Reuning.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Digoxin

Year: 1974 PMID： 4449007 DOI： 10.1007/BF01061404

Source DB: PubMed Journal: J Pharmacokinet Biopharm ISSN： 0090-466X

× No keyword cloud information.

9 in total

1. THE METABOLISM OF DIGOXIN IN NORMAL SUBJECTS.

Authors: F I MARCUS; G J KAPADIA; G G KAPADIA
Journal: J Pharmacol Exp Ther Date: 1964-08 Impact factor: 4.030

2. Statistical estimations in pharmacokinetics.

Authors: H G Boxenbaum; S Riegelman; R M Elashoff
Journal: J Pharmacokinet Biopharm Date: 1974-04

3. Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.

Authors: R H Reuning; R A Sams; R E Notari
Journal: J Clin Pharmacol New Drugs Date: 1973-04

4. The specificity of the digoxin radioimmunoassay procedure.

Authors: R G Stoll; M S Christensen; E Sakmar; J G Wagner
Journal: Res Commun Chem Pathol Pharmacol Date: 1972-11

5. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.

Authors: L Z Benet
Journal: J Pharm Sci Date: 1972-04 Impact factor: 3.534

6. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors: T W Smith; V P Butler; E Haber
Journal: N Engl J Med Date: 1969-11-27 Impact factor: 91.245

7. Some pharmacokinetic aspects of 5-(dimethylriazeno)-imidazole-4-carboxamide in the dog.

Authors: T L Loo; B B Tanner; G E Housholder; B J Shepard
Journal: J Pharm Sci Date: 1968-12 Impact factor: 3.534

8. Localization of the renal excretion of the tritiated digoxin.

Authors: J E Doherty; C B Ferrell; E J Towbin
Journal: Am J Med Sci Date: 1969-09 Impact factor: 2.378

9. Administration of tritiated digoxin with and without a loading dose. A metabolic study.

Authors: F I Marcus; L Burkhalter; C Cuccia; J Pavlovich; G G Kapadia
Journal: Circulation Date: 1966-11 Impact factor: 29.690

9 in total

36 in total

Review 1. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors: L A Pagliaro; L Z Benet
Journal: J Pharmacokinet Biopharm Date: 1975-10

7. Residence time dispersion as a general measure of drug distribution kinetics: estimation and physiological interpretation.

Authors: Michael Weiss
Journal: Pharm Res Date: 2007-05-18 Impact factor: 4.200

Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.

1. THE METABOLISM OF DIGOXIN IN NORMAL SUBJECTS.

2. Statistical estimations in pharmacokinetics.

3. Role of pharmacokinetics in drug dosage adjustment. I. Pharmacologic effect kinetics and apparent volume of distribution of digoxin.

4. The specificity of the digoxin radioimmunoassay procedure.

5. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.

6. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

7. Some pharmacokinetic aspects of 5-(dimethylriazeno)-imidazole-4-carboxamide in the dog.

8. Localization of the renal excretion of the tritiated digoxin.

9. Administration of tritiated digoxin with and without a loading dose. A metabolic study.

Review 1. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

2. Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

3. The pharmacokinetics of trilostane and ketotrilostane in an interconverting system in the rat.

4. The pharmacokinetics of chlormethiazole following intravenous administration in the aged.

5. Bioavailability of beta-acetyldigoxin after single and repeated doses of tablets and solution.

Review 6. Rate and extent of drug accumulation after multiple dosing revisited.

7. Residence time dispersion as a general measure of drug distribution kinetics: estimation and physiological interpretation.

8. Exponential tails of drug disposition curves: reality or appearance?

9. Pharmacokinetic quantitation of naltrexone controlled release from a copolymer delivery system.

Review 10. Clinical pharmacokinetics of digoxin.